FDA Unveils Risk-Based Enforcement Approach to Homeopathic Drugs Post author:Sam Post published:December 19, 2017 Post category:Drug Industry Daily In a new policy initiative, the FDA outlined new enforcement measures for homeopathic products. Source: Drug Industry Daily You Might Also Like Senators Launch Investigations on Orphan Drugs March 6, 2017 FDA Slaps Foghorn With Another Clinical Hold on its Anticancer Line April 25, 2023 Valeant Files Patent Lawsuit Over Zydus’ Cardizem Generic January 25, 2017